Cipla USA, Inc. has voluntarily recalled 92,376 tubes of Diclofenac Sodium Topical Gel, 1% (generic Voltaren), which is used for treating arthritis pain. The recall was initiated because the product failed to meet specific pH requirements, which can affect the drug's stability or effectiveness. This medication was distributed nationwide across the United States in 100-gram (3.53-ounce) tubes.
The product does not meet internal chemical specifications for pH levels, which may impact how the medication performs or its shelf-life stability.
You have 2 options:
Manufactured by: DPT Laboratories, Ltd., San Antonio, TX.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.